TriSalus Life Sciences, Inc. Earnings Per Share (Basic)
TriSalus Life Sciences, Inc. (TLSI) reported Earnings Per Share (Basic) of -$0.16 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- TriSalus Life Sciences, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.16.
- TriSalus Life Sciences, Inc. earnings per share, basic for the quarter ending 2026-03-31 was $0.03.
- TriSalus Life Sciences, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.21.
- TriSalus Life Sciences, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.96.
- TriSalus Life Sciences, Inc. earnings per share, basic for fiscal 2025 was -$1.84.
- TriSalus Life Sciences, Inc. earnings per share, basic for fiscal 2024 was -$1.31.
- TriSalus Life Sciences, Inc. earnings per share, basic for fiscal 2023 was -$6.77.
- TriSalus Life Sciences, Inc. earnings per share, basic for fiscal 2022 was -$161.55.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.16 10-Q · filed 2026-08-06 | -$0.14 10-Q · filed 2026-08-06 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.17 derived: net income ÷ weighted average shares · filed 2026-08-06 | |||
| 2026-03-31 | $0.03 10-Q · filed 2026-05-12 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.05 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.34 derived: net income ÷ weighted average shares · filed 2026-08-06 | |||
| 2025-12-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$1.13 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$1.46 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.84 10-K · filed 2026-03-05 | |||
| 2025-09-30 | -$0.96 10-Q · filed 2025-11-13 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.72 10-Q · filed 2025-11-13 | -$2.19 derived: net income ÷ weighted average shares · filed 2026-08-06 | |||
| 2025-06-30 | -$0.27 10-Q · filed 2026-08-06 | -$0.65 10-Q · filed 2026-08-06 | -$1.04 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.18 derived: net income ÷ weighted average shares · filed 2026-08-06 | |||
| 2025-03-31 | -$0.39 10-Q · filed 2026-05-12 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.91 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.14 derived: net income ÷ weighted average shares · filed 2026-05-12 | |||
| 2024-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$1.31 10-K · filed 2026-03-05 | |||
| 2024-09-30 | -$0.12 10-Q · filed 2025-11-13 | -$0.33 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.91 10-Q · filed 2025-11-13 | -$2.42 derived: net income ÷ weighted average shares · filed 2025-11-13 | |||
| 2024-06-30 | -$0.21 10-Q · filed 2025-08-12 | -$0.81 10-Q · filed 2025-08-12 | -$2.36 derived: net income ÷ weighted average shares · filed 2025-08-12 | -$2.74 derived: net income ÷ weighted average shares · filed 2025-08-12 | |||
| 2024-03-31 | -$0.60 10-K/A · filed 2025-05-30 | -$2.16 derived: net income ÷ weighted average shares · filed 2025-05-30 | -$2.62 derived: net income ÷ weighted average shares · filed 2025-05-30 | -$4.53 derived: net income ÷ weighted average shares · filed 2025-05-30 | |||
| 2023-12-31 | -$1.56 derived: net income ÷ weighted average shares · filed 2025-05-30 | -$2.10 derived: net income ÷ weighted average shares · filed 2025-05-30 | -$4.41 derived: net income ÷ weighted average shares · filed 2025-05-30 | -$6.77 10-K/A · filed 2025-05-30 | -$6.73 10-K · filed 2024-04-11 | ||
| 2023-09-30 | -$0.14 10-Q · filed 2024-11-14 | -$0.13 10-Q · filed 2023-11-14 | -$2.63 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$5.72 10-Q · filed 2024-11-14 | -$5.68 10-Q · filed 2023-11-14 | -$6.97 derived: net income ÷ weighted average shares · filed 2024-11-14 | |
| 2023-06-30 | -$35.84 10-Q · filed 2024-08-14 | -$59.79 10-Q · filed 2024-08-14 | -$8.95 derived: net income ÷ weighted average shares · filed 2024-08-14 | -$13.60 derived: net income ÷ weighted average shares · filed 2024-08-14 | |||
| 2023-03-31 | -$0.57 10-Q · filed 2024-05-15 | -$4.19 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$7.62 derived: net income ÷ weighted average shares · filed 2024-05-15 | ||||
| 2022-12-31 | -$74.92 derived: net income ÷ weighted average shares · filed 2024-04-11 | -$102.89 derived: net income ÷ weighted average shares · filed 2024-04-11 | -$161.55 10-K · filed 2024-04-11 | ||||
| 2022-09-30 | -$25.95 10-Q · filed 2023-11-14 | -$82.17 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |